Anteris Technologies Global (AVR) Common Equity (2024 - 2026)
Anteris Technologies Global's (AVR) quarterly Common Equity came in at $251.7 million in Q2 2026, up 947.23% year-over-year from $24.0 million in Q2 2025, and down 9.6% quarter-over-quarter from $278.4 million in Q1 2026.
Analysis
Anteris Technologies Global (AVR) Common Equity (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Common Equity for 3 consecutive years, with $251.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Common Equity rose 947.23% year-over-year to $251.7 million in Q2 2026; TTM through Jun 2026 was $251.7 million, a 947.23% increase from a year earlier, with the FY2025 full-year figure at -$253000.0, down 100.4% from the prior year.
- Common Equity was $251.7 million for Q2 2026 at Anteris Technologies Global, down from $278.4 million in the prior quarter.
- Over five years, Common Equity peaked at $278.4 million in Q1 2026 and troughed at -$253000.0 in Q4 2025.
- A 3-year average of $67.3 million and a median of $14.2 million in 2024 frame the typical range for Common Equity.
- Across the five-year window, Common Equity tumbled 100.4% in 2025 and jumped 947.23% in 2026, its largest moves.
- Over 3 years, Common Equity stood at $62.7 million in 2024, then slumped by 100.4% to -$253000.0 in 2025, then surged by 99574.31% to $251.7 million in 2026.
- The last three Common Equity figures came in at $251.7 million (Q2 2026), $278.4 million (Q1 2026), and -$253000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Anteris Technologies Global | 816.49 Mn | 816.49 Mn | 776,000.00 | 251.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 251.67 Mn |
| Mar 31, 2026 | 278.41 Mn |
| Dec 31, 2025 | -253,000.00 |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 24.03 Mn |
| Mar 31, 2025 | 43.11 Mn |
| Dec 31, 2024 | 62.68 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 4.40 Mn |